Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-07

Clinical Trial Update: A Study to Evaluate the Pharmacokinetics of Abatacept Converted From Drug Substance by Two Different Processes [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating abatacept converted from drug substance by two processes; completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abatacept (abatacept)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED | Results posted: 2021-01-07